Varian acquired Cancer Treatment Services International for $283m.

Taking an important step to accelerate innovation of new multidisciplinary solutions to address the growing global cancer burden, Varian Medical Systems has entered into a definitive agreement to acquire Cancer Treatment Services International (CTSI) for $283m. CTSI operates the American Oncology Institute in Hyderabad and 10 multidisciplinary—radiation, medical and surgical oncology— cancer centers across the Indian subcontinent as well as a US-based Oncology Solutions division that provides cancer care professional services to healthcare providers worldwide. "Our acquisition of CTSI is consistent with this strategy and will allow us to better support oncology centers globally, accelerate access to technology-driven care and build a feedback loop that will drive cost-effective innovation. We look forward to pooling the ingenuity of our combined team with the power of data, technology and clinical insights to achieve new victories against cancer, especially for the millions of patients globally without access to appropriate care." Dow Wilson, Varian president and chief executive officer.